Markus Wartenberg

1.4k total citations
11 papers, 44 citations indexed

About

Markus Wartenberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Markus Wartenberg has authored 11 papers receiving a total of 44 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Economics and Econometrics. Recurrent topics in Markus Wartenberg's work include Sarcoma Diagnosis and Treatment (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Economic and Financial Impacts of Cancer (2 papers). Markus Wartenberg is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Economic and Financial Impacts of Cancer (2 papers). Markus Wartenberg collaborates with scholars based in Germany, Italy and United Kingdom. Markus Wartenberg's co-authors include Bernd Kasper, Roger Wilson, Denise K. Reinke, Ulrich Ronellenfitsch, Suzanne Wait, Nicolás Fernández, Olga Husson, Jens Jakob, Jean‐Yves Blay and Sarah Dumont and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and BMC Cancer.

In The Last Decade

Markus Wartenberg

11 papers receiving 42 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Wartenberg Germany 4 29 18 10 8 8 11 44
Özlem Özkul Türkiye 6 15 0.5× 30 1.7× 7 0.7× 7 0.9× 4 0.5× 12 76
Michela Libertini Italy 4 22 0.8× 50 2.8× 10 1.0× 15 1.9× 4 0.5× 13 81
Carmelo Gaudioso United States 5 46 1.6× 20 1.1× 14 1.4× 9 1.1× 8 1.0× 13 93
Junjie Huang Hong Kong 6 60 2.1× 27 1.5× 7 0.7× 12 1.5× 2 0.3× 18 108
Adam Kimble United Kingdom 3 54 1.9× 23 1.3× 12 1.2× 37 4.6× 4 0.5× 3 103
Xanthi Coskinas Australia 5 30 1.0× 12 0.7× 28 2.8× 15 1.9× 12 1.5× 16 59
Inga Jóna Ingimarsdóttir Iceland 4 53 1.8× 23 1.3× 10 1.0× 8 1.0× 3 0.4× 13 84
Danielle Riley United States 5 11 0.4× 41 2.3× 15 1.5× 21 2.6× 5 0.6× 8 80
Juan Antonio Virizuela Echaburu Spain 5 22 0.8× 22 1.2× 6 0.6× 30 3.8× 4 0.5× 14 77
Ena Agbodza United States 2 18 0.6× 15 0.8× 4 0.4× 6 0.8× 2 0.3× 2 40

Countries citing papers authored by Markus Wartenberg

Since Specialization
Citations

This map shows the geographic impact of Markus Wartenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Wartenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Wartenberg more than expected).

Fields of papers citing papers by Markus Wartenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Wartenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Wartenberg. The network helps show where Markus Wartenberg may publish in the future.

Co-authorship network of co-authors of Markus Wartenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Wartenberg. A scholar is included among the top collaborators of Markus Wartenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Wartenberg. Markus Wartenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Kasper, Bernd, Roger Wilson, Jean‐Yves Blay, et al.. (2022). Global Patient Involvement in Sarcoma Care—A Collaborative Initiative of the Connective Tissue Oncology Society (CTOS) & Sarcoma Patients EuroNet (SPAEN). Cancers. 14(4). 854–854. 5 indexed citations
3.
Husson, Olga, Marije E. Weidema, Markus Wartenberg, et al.. (2022). Setting the international research agenda for sarcoma together with patients and carers: first results of the Sarcoma Patient EuroNet (SPAEN) priority setting partnership. ESMO Open. 7(3). 100509–100509. 7 indexed citations
4.
Westphalen, C. Benedikt, Michael Quante, Markus Wartenberg, et al.. (2022). Sektorenübergreifende interdisziplinäre Zusammenarbeit der Arbeitsgemeinschaft Internistische Onkologie in der Präzisionsonkologie. Der Onkologe. 28(S1). 6–16. 1 indexed citations
5.
Wartenberg, Markus, et al.. (2020). Career and Financial Situation of Patients Diagnosed with Soft Tissue Sarcomas. Oncology Research and Treatment. 43(10). 539–548. 3 indexed citations
6.
Kasper, Bernd, Suzanne Wait, Roger Wilson, et al.. (2018). Working to improve the management of sarcoma patients across Europe: a policy checklist. BMC Cancer. 18(1). 424–424. 17 indexed citations
7.
Avouac, Bernard, Magdolna Dank, Karina Jahnz‐Różyk, et al.. (2017). Real World Evidence In Europe - The Results Of An Expert Survey. Value in Health. 20(9). A655–A655. 1 indexed citations
8.
Jakob, Jens, Ulrich Ronellenfitsch, Markus Wartenberg, et al.. (2017). Behandlung retroperitonealer Sarkome in Deutschland. Der Chirurg. 89(1). 50–55. 6 indexed citations
9.
Wilson, Richard H., et al.. (2017). Sarcoma care pathways – the patient viewpoint. European Journal of Cancer. 72. S6–S6. 1 indexed citations
10.
Gill, Jennifer, Panos Kanavos, Karina Jahnz‐Różyk, et al.. (2017). RWE in Europe Paper II: The use of Real World Evidence in the disease context. London School of Economics and Political Science Research Online (London School of Economics and Political Science). 1 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Özlem Özkul Breakdown of academic impact, for papers by Michela Libertini Breakdown of academic impact, for papers by Carmelo Gaudioso Breakdown of academic impact, for papers by Junjie Huang Breakdown of academic impact, for papers by Adam Kimble Breakdown of academic impact, for papers by Xanthi Coskinas Breakdown of academic impact, for papers by Inga Jóna Ingimarsdóttir Breakdown of academic impact, for papers by Danielle Riley Breakdown of academic impact, for papers by Juan Antonio Virizuela Echaburu Breakdown of academic impact, for papers by Ena Agbodza
Rankless by CCL
2026